SEC Form 4 · accession 0001144204-17-052797
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack W Schuler
Director · 10% Owner
Period of report
Oct 13, 2017
Accepted (ET)
Oct 17, 2017 · 3:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3,F7 | Oct 13, 2017 | P | 29,240 | $18.81 | A | 12,921,945 | I | By Jack W. Schuler Living Trust |
| Common StockF2,F3,F7 | Oct 13, 2017 | P | 32,060 | $19.72 | A | 12,954,005 | I | By Jack W. Schuler Living Trust |
| Common StockF4,F7 | holding | — | — | — | 952,678 | I | By Schuler Family Foundation | |
| Common StockF5,F7 | holding | — | — | — | 689,355 | I | By Schuler Grandchildren LLC | |
| Common StockF6,F7 | holding | — | — | — | 689,355 | I | By Schuler GC 2010 Continuation Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.45 to $19.40, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.45 to $20.05, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.
- F4Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.
- F5Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as manager of Schuler Grandchildren LLC.
- F6Mr. Schuler has shared voting and dispositive power with respect to such shares in his capacity as the grantor of Schuler GC 2010 Continuation Trust.
- F7The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.